Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed furnish the details of loss of share certificates/ request for issue of duplicate share certificate reported by shareholder of the Company, received from Registrar and Transfer Agent, Link Intime India on June 19, 2022.
The above information is a part of company’s filings submitted to BSE.